相关实验视频

Updated: Jun 12, 2025

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles

Published on: August 17, 2022

疫苗制造技术的比较复合DNA与体外转录 (IVT) 的mRNA

Christina Davidopoulou¹, Dimitrios Kouvelas², Andreas Ouranidis^3,4

¹Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece.

Scientific reports

|September 17, 2024

概括

重组DNA疫苗的制造提供了更高的利能力和成熟的质量. 在体外 (IVT) mRNA疫苗制造为新疫苗提供了更快的进入市场和灵活性.

科学领域:

生物技术是生物技术.
疫苗学疫苗学疫苗学
工艺工程的过程工程.

背景情况:

疫苗制造对于传染病控制至关重要.
重组DNA和体外 (IVT) mRNA技术是现代疫苗生产的关键.
缺乏对这些平台进行比较技术经济分析.

研究的目的:

对复合DNA和IVTmRNA疫苗制造平台进行一个公正的,比较的技术经济研究.
评估每个技术的技术优点,负债和成本情景.
为了确定平台适合单克隆抗体和抗原.

主要方法:

使用数字影子模拟来模拟这两种制造技术.
对根本原因偏差,技术优点和负债的分析.
评估成本情景,包括资本和起始材料要求.

主要成果:

由于资本和材料成本较低,重组DNA技术显示了更高的利率指数,导致每剂最低销售价格较低.
IVT mRNA技术在效力,简化合成,可扩展性和原材料可用性方面具有优势.
对于快速透市场和在需要短开发周期时的产品灵活性,mRNA疫苗是可取的.

结论:

再组合DNA制造对已建立的优质产品经济有利.
IVT mRNA制造提供了敏捷性和速度,这对于新出现的威胁和快速疫苗开发至关重要.
平台之间的选择取决于具体的疫苗目标和市场需求.

关键词:

抗原是一种抗原.将mRNA疫苗制造业进行比较数字影子数字影子数字双胞胎是一个数字双胞胎.在IVT的mRNA中.工业5.0 工业 5.0 工业 5.0 工业 5.0 工业单克隆抗体是一种单克隆抗体.过程建模的过程建模.再组合DNA的复合DNA是什么?技术经济学研究

更多相关视频

Optimization of In vitro Transcription Reaction for mRNA Production Using Chromatographic At-Line Monitoring

Optimization of In vitro Transcription Reaction for mRNA Production Using Chromatographic At-Line Monitoring

Published on: April 4, 2025

In Vitro Synthesis of Modified mRNA for Induction of Protein Expression in Human Cells

In Vitro Synthesis of Modified mRNA for Induction of Protein Expression in Human Cells

Published on: November 13, 2014

相关概念视频

Recombinant DNA

Recombinant DNA

The Central Dogma

The Central Dogma

The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...

Complementary DNA

Complementary DNA

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...